Issue
Date Log
Copyright (c) 2026 Abduallah Hamad Mayuf Alanazi, Asma Ali Mayiq Alanazi, Mjahd Mufeed Aljawad, Ahmed Mofareh Alanazi, Khalid Mohammed Saedd Al Jabir, Faisal Mukaymin Alanazi, Hamoud Nahi Alanazi

This work is licensed under a Creative Commons Attribution 4.0 International License.
Emergency Assessment, Initial Stabilization, and Definitive Management of Perforated Peptic Ulcer Disease in the Emergency Department-An Updated Review
Corresponding Author(s) : Abduallah Hamad Mayuf Alanazi
Saudi Journal of Medicine and Public Health,
Vol. 3 No. 1 (2026)
Abstract
Background: Perforated peptic ulcer (PPU) is a life-threatening complication of peptic ulcer disease characterized by disruption of the gastric or duodenal wall, resulting in leakage of gastrointestinal contents into the peritoneal cavity. Despite advances in diagnostic imaging, surgical techniques, and perioperative care, PPU remains associated with substantial morbidity and mortality, particularly among older patients and individuals with comorbidities or delayed presentation.
Aim: This review aims to provide a comprehensive overview of PPU, emphasizing its etiology, epidemiology, pathophysiology, histopathological characteristics, clinical presentation, diagnostic evaluation, treatment strategies, differential diagnosis, and prognosis.
Methods: A narrative review approach was used to synthesize the available literature on PPU, focusing on its underlying mechanisms, clinical manifestations, diagnostic methods, and contemporary management principles. Relevant evidence addressing conservative treatment, surgical intervention, antimicrobial therapy, and prognostic determinants was considered.
Results: PPU most commonly develops in association with Helicobacter pylori infection and nonsteroidal anti-inflammatory drug use. Clinical presentation typically includes sudden-onset abdominal pain and signs of peritoneal irritation, although manifestations may be atypical in older or critically ill patients. Diagnosis relies on clinical assessment, laboratory investigations, and imaging, particularly computed tomography. Management requires prompt resuscitation, broad-spectrum antibiotics, acid suppression, and timely surgical assessment. Operative repair remains the principal treatment for most patients, whereas nonoperative management is appropriate only in carefully selected cases without ongoing leakage or clinical deterioration. Delayed treatment, advanced age, shock, and comorbidities are important predictors of adverse outcomes.
Conclusion: Early recognition, rapid resuscitation, appropriate source control, and individualized management are essential to improve outcomes in PPU.
Keywords
Download Citation
Endnote/Zotero/Mendeley (RIS)BibTeX
- 1. Lanas A, Chan FKL. Peptic ulcer disease. Lancet. 2017 Aug 05;390(10094):613-624.
- 2. Gisbert JP, Legido J, García-Sanz I, Pajares JM. Helicobacter pylori and perforated peptic ulcer prevalence of the infection and role of non-steroidal anti-inflammatory drugs. Dig Liver Dis. 2004 Feb;36(2):116-20.
- 3. Kavitt RT, Lipowska AM, Anyane-Yeboa A, Gralnek IM. Diagnosis and Treatment of Peptic Ulcer Disease. Am J Med. 2019 Apr;132(4):447-456.
- 4. Rosenstock S, Jørgensen T, Bonnevie O, Andersen L. Risk factors for peptic ulcer disease: a population based prospective cohort study comprising 2416 Danish adults. Gut. 2003 Feb;52(2):186-93.
- 5. Kempenich JW, Sirinek KR. Acid Peptic Disease. Surg Clin North Am. 2018 Oct;98(5):933-944.
- 6. Lau JY, Sung J, Hill C, Henderson C, Howden CW, Metz DC. Systematic review of the epidemiology of complicated peptic ulcer disease: incidence, recurrence, risk factors and mortality. Digestion. 2011;84(2):102-13.
- 7. Søreide K, Thorsen K, Harrison EM, Bingener J, Møller MH, Ohene-Yeboah M, Søreide JA. Perforated peptic ulcer. Lancet. 2015 Sep 26;386(10000):1288-1298.
- 8. Chernyshev VN, Aleksandrov IK. [Classification of stomach ulcers and choice of the surgery method]. Khirurgiia (Mosk). 1992 Sep-Oct;(9-10):3-8.
- 9. Lv SX, Gan JH, Ma XG, Wang CC, Chen HM, Luo EP, Huang XP, Wu SH, Qin AL, Ke-Chen, Wang XH, Wei-Sun, Li-Chen, Ying-Xie, Hu FX, Dan-Niu, Walia S, Zhu J. Biopsy from the base and edge of gastric ulcer healing or complete healing may lead to detection of gastric cancer earlier: an 8 years endoscopic follow-up study. Hepatogastroenterology. 2012 May;59(115):947-50.
- 10. Amorena Muro E, Borda Celaya F, Martínez-Peñuela Virseda JM, Borobio Aguilar E, Oquiñena Legaz S, Jiménez Pérez FJ. [Analysis of the clinical benefits and cost-effectiveness of performing a systematic second-look gastroscopy in benign gastric ulcer]. Gastroenterol Hepatol. 2009 Jan;32(1):2-8.
- 11. Møller MH, Adamsen S, Thomsen RW, Møller AM. Preoperative prognostic factors for mortality in peptic ulcer perforation: a systematic review. Scand J Gastroenterol. 2010 Aug;45(7-8):785-805.
- 12. Krobot K, Yin D, Zhang Q, Sen S, Altendorf-Hofmann A, Scheele J, Sendt W. Effect of inappropriate initial empiric antibiotic therapy on outcome of patients with community-acquired intra-abdominal infections requiring surgery. Eur J Clin Microbiol Infect Dis. 2004 Sep;23(9):682-7.
- 13. Satoh K, Yoshino J, Akamatsu T, Itoh T, Kato M, Kamada T, Takagi A, Chiba T, Nomura S, Mizokami Y, Murakami K, Sakamoto C, Hiraishi H, Ichinose M, Uemura N, Goto H, Joh T, Miwa H, Sugano K, Shimosegawa T. Evidence-based clinical practice guidelines for peptic ulcer disease 2015. J Gastroenterol. 2016 Mar;51(3):177-94.
- 14. Surapaneni S, S R, Reddy A VB. The Perforation-Operation time Interval; An Important Mortality Indicator in Peptic Ulcer Perforation. J Clin Diagn Res. 2013 May;7(5):880-2.
References
1. Lanas A, Chan FKL. Peptic ulcer disease. Lancet. 2017 Aug 05;390(10094):613-624.
2. Gisbert JP, Legido J, García-Sanz I, Pajares JM. Helicobacter pylori and perforated peptic ulcer prevalence of the infection and role of non-steroidal anti-inflammatory drugs. Dig Liver Dis. 2004 Feb;36(2):116-20.
3. Kavitt RT, Lipowska AM, Anyane-Yeboa A, Gralnek IM. Diagnosis and Treatment of Peptic Ulcer Disease. Am J Med. 2019 Apr;132(4):447-456.
4. Rosenstock S, Jørgensen T, Bonnevie O, Andersen L. Risk factors for peptic ulcer disease: a population based prospective cohort study comprising 2416 Danish adults. Gut. 2003 Feb;52(2):186-93.
5. Kempenich JW, Sirinek KR. Acid Peptic Disease. Surg Clin North Am. 2018 Oct;98(5):933-944.
6. Lau JY, Sung J, Hill C, Henderson C, Howden CW, Metz DC. Systematic review of the epidemiology of complicated peptic ulcer disease: incidence, recurrence, risk factors and mortality. Digestion. 2011;84(2):102-13.
7. Søreide K, Thorsen K, Harrison EM, Bingener J, Møller MH, Ohene-Yeboah M, Søreide JA. Perforated peptic ulcer. Lancet. 2015 Sep 26;386(10000):1288-1298.
8. Chernyshev VN, Aleksandrov IK. [Classification of stomach ulcers and choice of the surgery method]. Khirurgiia (Mosk). 1992 Sep-Oct;(9-10):3-8.
9. Lv SX, Gan JH, Ma XG, Wang CC, Chen HM, Luo EP, Huang XP, Wu SH, Qin AL, Ke-Chen, Wang XH, Wei-Sun, Li-Chen, Ying-Xie, Hu FX, Dan-Niu, Walia S, Zhu J. Biopsy from the base and edge of gastric ulcer healing or complete healing may lead to detection of gastric cancer earlier: an 8 years endoscopic follow-up study. Hepatogastroenterology. 2012 May;59(115):947-50.
10. Amorena Muro E, Borda Celaya F, Martínez-Peñuela Virseda JM, Borobio Aguilar E, Oquiñena Legaz S, Jiménez Pérez FJ. [Analysis of the clinical benefits and cost-effectiveness of performing a systematic second-look gastroscopy in benign gastric ulcer]. Gastroenterol Hepatol. 2009 Jan;32(1):2-8.
11. Møller MH, Adamsen S, Thomsen RW, Møller AM. Preoperative prognostic factors for mortality in peptic ulcer perforation: a systematic review. Scand J Gastroenterol. 2010 Aug;45(7-8):785-805.
12. Krobot K, Yin D, Zhang Q, Sen S, Altendorf-Hofmann A, Scheele J, Sendt W. Effect of inappropriate initial empiric antibiotic therapy on outcome of patients with community-acquired intra-abdominal infections requiring surgery. Eur J Clin Microbiol Infect Dis. 2004 Sep;23(9):682-7.
13. Satoh K, Yoshino J, Akamatsu T, Itoh T, Kato M, Kamada T, Takagi A, Chiba T, Nomura S, Mizokami Y, Murakami K, Sakamoto C, Hiraishi H, Ichinose M, Uemura N, Goto H, Joh T, Miwa H, Sugano K, Shimosegawa T. Evidence-based clinical practice guidelines for peptic ulcer disease 2015. J Gastroenterol. 2016 Mar;51(3):177-94.
14. Surapaneni S, S R, Reddy A VB. The Perforation-Operation time Interval; An Important Mortality Indicator in Peptic Ulcer Perforation. J Clin Diagn Res. 2013 May;7(5):880-2.